Evidence map›Paper›PMID 42321867›Full record

ReviewMolecular neurodegeneration2026

Riboregulation: a non-canonical tau function.

Katherine R LeBlanc, Randall J Eck, Sarah J Benbow, Brian C Kraemer

Abstract readReview
In one paragraph

Review in Molecular neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katherine R LeBlanc *Molecular & Cellular Biology Graduate Program, University of Washington, Seattle, WA, 98195, USA.
Randall J Eck *Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, 98104, USA.
Sarah J BenbowDivision of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, 98104, USA.
Brian C KraemerMolecular & Cellular Biology Graduate Program, University of Washington, Seattle, WA, 98195, USA. kraemerb@uw.edu.

Funding

Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLDR01NS064131 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI KRAEMER, BRIAN C. · 2009 to 2022
$5.0M
Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathologyR01AG084680 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI KRAEMER, BRIAN C. · 2023 to 2025
$1.9M
Mutant Tubulins Confer Resistance to Pathological TauR00AG073455 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI Sarah Jean Zimmerman Benbow · 2024 to 2026
$742k
Disruptions to nuclear proteostasis machinery as drivers of neurodegeneration in dementia.F99AG088436 · NIA · UNIVERSITY OF WASHINGTON · PI ECK, RANDALL · 2024 to 2025
$100k
BLRD VA IK6 BX006467NIA NIH HHS F99 AG088436NIA NIH HHS R00 AG073455NIA NIH HHS R01 AG084680NIA NIH HHS T32 AG052354NINDS NIH HHS R01 NS064131
6 · The paper itself

Abstract

Almost since its discovery, tau protein has perplexed scientists and clinicians with its varied roles in physiology as well as its appearance as phosphorylated protein aggregates of various structures in many neurodegenerative diseases. Tau plays a role in microtubule stabilization, but from the earliest of studies, tau has also been observed to bind to RNA, with recent research suggesting tau has a higher affinity for some RNA species compared to microtubules. In the context of disease, tau dysfunction potentiates disruptions to RNA metabolism, including the perturbation of mRNA splicing, impairment of translation, de-repression of transposable elements, and alteration of RNA export and degradation. Tau aggregates directly sequester diverse RNA species and RNA binding proteins. Emerging evidence reinforces the characterization of tau as an RNA binding protein, highlighting questions about both the physiological and disease-related functions of this direct RNA binding. The disparate structure of tau in normal and various disease states makes teasing apart the various impacts on RNA and regulation a more difficult puzzle requiring future study. In this review, we summarize the evidence for tau's role in RNA biology, including as an RNA binding protein.

Indexed as

RNARNA-Binding ProteinsTauopathiestau ProteinsAnimalsHumansRNARNA-Binding Proteinstau ProteinsAlzheimer’s diseaseRNA metabolismTauopathy

Identifiers

PMID42321867
PMCPMC13548662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.